Cervical carcinoma and sexual behavior: Collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1060-1069

  Appleby, Paul ^b   Beral, Valerie ^b   De González, Amy Berrington ^b   Colin, Didier ^b   Franceschi, Silvia ^b   Green, Jane ^b   La Vecchia, Carlo ^b   Peto, Julian ^b   Plummer, Martyn ^a   Sweetland, Sian ^b   Bosch, F Xavier ^b   Herrero, Rolando ^b   Hildesheim, Allan ^b   Skegg, David ^b   Thomas, David ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DNA, VIRAL; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 66649131375     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1186     Document Type: Article

References (72)

1. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973;33:1353-1367
2. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1:1037-1040
3. Boyd JT, Doll R. A study of the aetiology of carcinoma of the cervix uteri. Br J Cancer 1964;13:419-434
4. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2:1010-1015 (Pubitemid 11027577)
5. IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol.64: Human papillomaviruses. Lyon: IARC Press; 1995.
6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19 (Pubitemid 29406813)
7. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data on 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-1621
8. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-1495
9. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women withcervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119:1108-1124
10. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-891
11. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991;10:1025-1035
12. Plummer M. Improved estimates of floating absolute risk. Stat Med 2004;23:93-104. (Pubitemid 38072109)
13. Boyce JG, Lu T, Nelson JH, Jr., Fruchter RG. Oral contraceptives and cervical carcinoma. Am J Obstet Gynecol 1977;128:761-766 (Pubitemid 8162774)
14. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. Am J Epidemiol 1987;126:592-604. (Pubitemid 17142231)
15. Thomas DB. An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix. Am J Epidemiol 1973;98:10-28.
16. Ebeling K, Nischan P, Schindler C. Use of oral contraceptives and risk of invasive cervical cancer in previously screened women. Int J Cancer 1987;39:427-430 (Pubitemid 17059765)
17. Hsieh CY, You SL, Kao CL, Chen CJ. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res 1999;19:4495-4500 (Pubitemid 30042813)
18. Irwin KL, Rosero-Bixby L, Oberle MW, et al. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? JAMA 1988;259:59-64.
19. Lazcano-Ponce EC, Hernandez-Avila M, Lopez-Carrillo L, et al. [Reproductive risk factors and sexual history associated with cervical cancer in Mexico]. Rev Invest Clin 1995;47:377-385
20. Slattery ML, Robison LM, Schuman KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989;261:1593-1598 (Pubitemid 19072230)
21. Stone KM, Zaidi A, Rosero-Bixby L, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 1995;6:409-414
22. Stone KM. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995;20 Suppl 1:S91-7.
23. Talbott E, Norman S, Kuller L, et al. Refining preventive strategies for invasive cervical cancer: a population-based case-control study. J Womens Health1995; 4:387-395
24. Shapiro S, Rosenberg L, Hoffman M, et al. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control 2003;14:485-495 (Pubitemid 36999984)
25. Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007;335:651-654 (Pubitemid 47548456)
26. Gram IT, Austin H, Stalsberg H. Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 1992;135:341-346
27. Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group. Breast Cancer Res 1999;1:73-80.
28. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer - further findings from the Oxford Family Planning Association contraceptive study. Br J Cancer 1996;73:1291-1297 (Pubitemid 26162349)
29. Ylitalo N, Sorensen P, Josefsson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999;81:357-365 (Pubitemid 29165193)
30. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000;83:1565-1572
31. Castle PE, Shields T, Kirnbauer R, et al. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity. Sex Transm Dis 2002;29:182-187 (Pubitemid 34219632)
32. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572.
33. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-1226 (Pubitemid 32511340)
34. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 1986;77:1063-1077 (Pubitemid 17184128)
35. Brinton LA, Hamman RF, Huggins GR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987;79:23-30. (Pubitemid 17102546)
36. Kjaer SK, Dahl C, Engholm G, Bock JE, Lynge E, Jensen OM. Case-control study of risk factors for cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections. Cancer Causes Control 1992;3:339-348
37. Cuzick J, Singer A, De Stavola BL, Chomet J. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 1990;26:684-690 (Pubitemid 20275100)
38. Green J, Berrington de González A, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003;89:2078-2086 (Pubitemid 38030906)
39. Ursin G, Pike MC, Preston-Martin S, d'Ablaing G, III, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control 1996;7:391-401.
40. Bosch FX, Muñoz N, de Sanjosé S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-758
41. Cuzick J, Sasieni P, Singer A. Risk factors for invasive cervix cancer in young women. Eur J Cancer 1996;32A:836-841 (Pubitemid 26178534)
42. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996;5:541-548 (Pubitemid 26235021)
43. Madeleine MM, Daling JR, Schwartz SM, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001;10:171-177 (Pubitemid 34288526)
44. Lacey JV, Jr., Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999;8:1079-1085 (Pubitemid 30004905)
45. Silins I, Wang X, Tadesse A, et al. A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol 2004;93:484-492 (Pubitemid 38507623)
46. WHO. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steriod Contraceptives. Int J Cancer 1993;55:228-236
47. La Vecchia C, Franceschi S, Decarli A, et al. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986;58:935-941 (Pubitemid 16035296)
48. Parazzini F, Chatenoud L, La Vecchia C, Chiaffarino F, Ricci E, Negri E. Time since last use of oral contraceptives and risk of invasive cervical cancer. Eur J Cancer 1998;34:884-888 (Pubitemid 28248501)
49. Thomas DB, Qin Q, Kuypers J, et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001;153:732-739 (Pubitemid 32319699)
50. Thomas DB, Ray RM, Koetsawang A, et al. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas withh uman papillomavirus types 16 and 18 DNA. Am J Epidemiol 2001;153:723-731
51. Herrero R, Brinton LA, Reeves WC, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a highrisk population. Cancer 1990;65:380-386 (Pubitemid 20035371)
52. Muñoz N, Bosch FX, de Sanjosé S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:423-431
53. Rolón PA, Smith JS, Muñoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000;85:486-491 (Pubitemid 30075125)
54. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-119 (Pubitemid 24021832)
55. Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-57 (Pubitemid 28078081)
56. Bayo S, Bosch FX, de Sanjosé S, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-209 (Pubitemid 34284928)
57. Ngelangel C, Muñoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-49 (Pubitemid 28078080)
58. Chaouki N, Bosch FX, Muñoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-554 (Pubitemid 28094099)
59. Santos C, Muñoz N, Klug S, et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-971 (Pubitemid 33015998)
60. Hammouda D, Muñoz N, Herrero R, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005;113:483-489 (Pubitemid 40038719)
61. Franceschi S, Rajkumar T, Vaccarella S, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003;107:127-133 (Pubitemid 37100096)
62. Sitas F, Urban M, Stein L, et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer 2007;2:6.
63. Stein L, Urban MI, O'Connell D, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer 2008;122:2260-2265
64. Burchell AN, Richardson H, Mahmud SM, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006;163:534-543
65. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005;191:731-738 (Pubitemid 40271061)
66. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
67. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-434
68. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-256 (Pubitemid 38942814)
69. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use and HPV: pooled analysis of the International Agency for Researchon Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-333 (Pubitemid 43342183)
70. Collins S, Mazloomzadeh S, Winter H, et al. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 2005;114:498-500. (Pubitemid 40279976)
71. Schroder KE, Carey MP, Vanable PA. Methodological challenges in researchon sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med 2003;26:104-123
72. The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ : a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-1868